
Abbott Laboratories ABT
Quarterly report 2026-Q1
added 04-29-2026
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NYSESPB |
Shares |
1.74 B |
Market Cap[1] |
$ 159 B |
EBITDA (LTM) |
$ 8.49 B |
P/E (LTM) |
26.1 |
P/S (LTM) |
3.5 |
EPS (LTM) |
3.34 |
Abbott Laboratories is a global healthcare company founded in 1888. The company develops and manufactures a wide range of medical devices, diagnostics, and nutritional products. Abbott's products and services are used by healthcare professionals and patients in over 160 countries.
Abbott is known for its innovative solutions for healthcare challenges. The company invests heavily in research and development to develop new products and technologies that improve patient outcomes and reduce healthcare costs. Abbott's areas of focus include cardiovascular, diabetes care, diagnostic imaging, infectious diseases, nutrition, and pharmaceuticals.
Abbott is committed to social responsibility and sustainability. The company aims to reduce its environmental impact and promote the use of renewable energy. Abbott also supports community health initiatives and disaster relief efforts around the world.
Overall, it's a significant player in the healthcare industry, with a strong commitment to innovation, quality, and sustainability. The company's products and services have a significant impact on patient outcomes and the global healthcare system.
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
- | - | $ 162 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 13.59 | 1.57 % | $ 385 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Alphatec Holdings
ATEC
|
$ 8.26 | 4.42 % | $ 1.24 B | Nasdaq Global Select Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.12 | 0.9 % | $ 19 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 1.48 | 7.25 % | $ 32.6 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
LivaNova PLC
LIVN
|
$ 77.17 | 3.17 % | $ 4.21 B | Nasdaq Global Select Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.42 | 2.0 % | $ 26.1 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.53 | 2.68 % | $ 62.2 M | Nasdaq Global Select Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 18.49 | 1.43 % | $ 434 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 11.69 | 6.86 % | $ 419 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Orthofix Medical
OFIX
|
$ 9.87 | 1.86 % | $ 391 M | Nasdaq Global Select Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.69 | 1.61 % | $ 68 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 36.29 | -2.13 % | $ 307 M | NYSE American | ||
|
MiMedx Group
MDXG
|
$ 3.71 | 0.27 % | $ 548 M | Nasdaq Global Select Market | ||
|
Butterfly Network
BFLY
|
$ 5.12 | 7.11 % | $ 1.27 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Myomo
MYO
|
$ 1.31 | 2.34 % | $ 54.8 M | NYSE American | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Globus Medical
GMED
|
$ 82.52 | 5.39 % | $ 11.2 B | NYSE,SPB | ||
|
Insulet Corporation
PODD
|
$ 159.61 | 5.35 % | $ 11.2 B | Nasdaq Global Select Market,SPB | ||
|
Profound Medical Corp.
PROF
|
$ 6.82 | 3.81 % | $ 206 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 36.9 | 6.99 % | $ 1.15 B | NYSE,SPB | ||
|
Inspire Medical Systems
INSP
|
$ 42.21 | 0.64 % | $ 1.24 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 94.1 | 2.41 % | $ 3.27 B | NYSE,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 87.54 | 1.97 % | $ 51.2 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 2.15 | 3.86 % | $ 5.96 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.